Defining the Ablative Dose for Y-90 TARE

Clinical trial NCT07586046 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07586046
Sponsor: Northwestern University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

HCC - Hepatocellular Carcinoma

Start date: 2026-05-01
Primary completion: 2029-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.